Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies

Par un écrivain mystérieux
Last updated 02 juin 2024
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
IJMS, Free Full-Text
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Subclinical Atherosclerosis: Part 1: What Is it? Can it Be Defined at the Histological Level?
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Atherosclerosis Nature Reviews Disease Primers
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Association of Abdominal Aorta Calcium and Coronary Artery Calcium with Incident Cardiovascular and Coronary Heart Disease Events in Black and White Middle‐Aged People: The Coronary Artery Risk Development in Young Adults Study
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Genetics: Implications for Prevention and Management of Coronary Artery Disease
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence - Pompilio Faggiano, Nicolò Dasseni, Nicola Gaibazzi, Andrea Rossi, Michael Henein, Gregg Pressman, 2019
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Advances in mechanical biomarkers - Eroles - 2023 - Journal of Molecular Recognition - Wiley Online Library
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
IJMS, Free Full-Text
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
IJMS, Free Full-Text
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
On the association between circulating biomarkers and atherosclerotic calcification in a cohort of arterial disease participants - Nutrition, Metabolism and Cardiovascular Diseases
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
Janet POWELL, Imperial College London, London, Imperial, BHF Centre of Research Excellence
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo:  Measurements Suitable for Biomarker and Mendelian Randomization Studies
IJMS, Free Full-Text

© 2014-2024 kingkaraoke-berlin.de. Inc. ou ses affiliés.